Trials / Completed
CompletedNCT05592262
Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects
A Randomized, Open-label, Single-dose, Two-cycle, Two-sequence, Cross-controlled Study Evaluating the Pharmacokinetic Effects of a High-fat Diet on Oral Administration of SHR2554 Tablets in Healthy Adult Subjects in China
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to assess the effect of food on the pharmacokinetics, and safety of SHR2554 Tablets in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR2554 | On an empty stomach - after meals |
| DRUG | SHR2554 | After meals - on an empty stomach |
Timeline
- Start date
- 2022-11-15
- Primary completion
- 2022-12-14
- Completion
- 2022-12-14
- First posted
- 2022-10-24
- Last updated
- 2022-12-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05592262. Inclusion in this directory is not an endorsement.